StockData
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc. (VIR) stock

VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3031% below fair value
$9.15−0.10 (-1.08%)

Close on Nov 18, 2026Market cap $1.55BP/E –Yield –

Vir Biotechnology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Vir Biotechnology's pe ratio was 6.6× on Apr 28, 2023, against 5.1× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20236.6×+3.6
2022Dec 30, 20223.0×–

More Vir Biotechnology figures

See a number that looks wrong?